Public Views and Usage of GLP-1 Drugs Revealed in Latest Health Tracking Poll
The latest KFF Health Tracking Poll reveals insights into public use and views of GLP-1 drugs, with 6% of adults currently using them for weight loss, diabetes, or heart disease. Despite increased awareness, affordability remains a concern, as 54% of adults find it challenging to cover costs. Usage is higher among adults with chronic conditions, highlighting accessibility and financial barriers faced by individuals seeking to benefit from GLP-1 drugs.
Misinformation Continues to Plague Public Discourse Four Years into COVID-19 Pandemic
Four years after the onset of the COVID-19 pandemic, misinformation continues to plague public discourse, with a shift in focus towards vaccine-related conspiracy theories. False claims linking COVID-19 symptoms to 5G wireless technology, untested treatments, and even denial of the virus’s existence contributed to the spread of misinformation. PolitiFact has conducted over 2,000 fact checks specifically related to COVID vaccines. It is crucial to remain vigilant against the spread of misinformation, particularly concerning public health measures and vaccination efforts.
The Evolving Landscape of Primary Care
Learn about the significant disruptions in primary care and their impact on patients and the healthcare system. Understand the evolving dynamics, key topics, implications for patients, industry developments, and the future outlook of primary care.